Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-15-007416
Filing Date
2015-02-06
Accepted
2015-02-06 15:43:11
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMENDMENT a15-3909_1sc13ga.htm SC 13G/A 69681
  Complete submission text file 0001104659-15-007416.txt   71096
Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 4152444990
TITAN PHARMACEUTICALS INC (Subject) CIK: 0000910267 (see all company filings)

EIN.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-46083 | Film No.: 15584325
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 1221 RIVERBEND DR STE 120 DALLAS TX 75247
Business Address
MEAD ROBERT E (Filed by) CIK: 0001040747 (see all company filings)

State of Incorp.: TX | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 0000